FDA Device Intelligence
Home › NEURENT MEDICAL LIMITED › NEUROMARK™ Device

NEUROMARK™ Device

NEURENT MEDICAL LIMITED · Model FS-002 · UDI-DI 05391537940002

GEI Prescription
1
510(k) clearances
119,015
Adverse events (469 deaths)
644
Recalls
861
Facilities

Description

The NEUROMARK System is intended for the application of radiofrequency (RF) energy to create lesions in mucosal tissue in otolaryngology [also known as Ear, Nose and Throat (ENT)] procedures in patients with chronic rhinitis. The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis. The NEUROMARK Device is a hand-held single-use bipolar radiofrequency device which comprises a handle, shaft, and treatment tip. The treatment tip, which is referred to as the End Effector, consists of an array of bipolar micro electrodes. These electrodes deliver bipolar radiofrequency energy while monitoring feedback on the tissue bio-impedance changes allowing for controlled radiofrequency energy level delivery. The NEUROMARK™ Device is operated via handle, slider and activation switch. The NEUROMARK Device is designed for use with the NEUROMARK Radiofrequency Generator. The NEUROMARK Device includes features to allow compatibility and authentication once connected, via a flexible cable, to the NEUROMARK Radiofrequency Generator.

Recalls

DateFirmReason
2026-08-18Olympus Corporation of the AmericasPotential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.
2026-06-08Stryker CorporationThere has been an increased amount in reported complaints consistently describing leaking from the handpiece during use.
2026-06-08Stryker CorporationThere has been an increased amount in reported complaints consistently describing leaking from the handpiece during use.
2026-06-02Maquet Cardiovascular, LLCGetinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-2878
2026-03-23Olympus Corporation of the AmericasPotential for detachment of a distal tip component of the device during use.
2026-03-23Olympus Corporation of the AmericasPotential for detachment of a distal tip component of the device during use.
2026-03-23Olympus Corporation of the AmericasPotential for detachment of a distal tip component of the device during use.
2026-03-23Olympus Corporation of the AmericasPotential for detachment of a distal tip component of the device during use.
2026-02-25Olympus Corporation of the AmericasOlympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting For
2026-02-25Olympus Corporation of the AmericasOlympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting For

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.